Results 71 to 80 of about 691 (170)

Construction and evaluation of a synthetic VNAR library for targeted antigen screening

open access: yesProtein Science
Abstract Sharks produce a unique antibody type, whose variable domain (VNAR) is the smallest known antibody fragment. VNARs possess high affinity, stability, and tissue penetration, making them attractive for biomedical applications.
Zu‐Ying Liu   +10 more
openaire   +2 more sources

A novel shark single-domain antibody targeting OGT as a tool for detection and intracellular localization

open access: yesFrontiers in Immunology, 2023
IntroductionO-GlcNAcylation is a type of reversible post-translational modification on Ser/Thr residues of intracellular proteins in eukaryotic cells, which is generated by the sole O-GlcNAc transferase (OGT) and removed by O-GlcNAcase (OGA).
Xiaozhi Xi   +21 more
doaj   +1 more source

Ueg Week 2020 Poster Presentations

open access: yes, 2020
United European Gastroenterology Journal, Volume 8, Issue S8, Page 144-887, October 2020.
wiley   +1 more source

An Anti-hTNF-α Variable New Antigen Receptor Format Demonstrates Superior in vivo Preclinical Efficacy to Humira® in a Transgenic Mouse Autoimmune Polyarthritis Disease Model

open access: yesFrontiers in Immunology, 2019
Tumor necrosis factor-alpha (TNF-α), an established pro-inflammatory cytokine plays a central role in the induction and progression of several chronic inflammatory and autoimmune diseases.
Obinna C. Ubah   +4 more
doaj   +1 more source

Vaccinoted Augmented Reality (VNAR): Vaccine Knowledge for Raising Awareness of Immunisation Among School Children

open access: yesMalaysia Journal of Invention and Innovation, 2023
People may now instantly obtain any information they desire thanks to the advancements in technology. Unfortunately, technological development can also result in grave issues, such as irresponsible anti-vaccine advocates who disseminate incorrect ...
Siti Nur Irdina Alwi, Suzidiana Sulaiman
doaj   +2 more sources

Anti-DLL4 VNAR targeted nanoparticles for targeting of both tumour and tumour associated vasculature

open access: yesNanoscale, 2020
Anti-DLL4 VNAR targeted nanoparticles – a novel targeting ligand towards an under-investigated target.
Adam Leach   +9 more
openaire   +4 more sources

Comparative analysis of expression levels of recombinant antibody fragments vNAR in Pichia pastoris and Escherchia coli

open access: yes, 2014
Los fragmentos de anticuerpo de dominio sencillo (~12 kDa), han mostrado ventajas sobre las moléculas de anticuerpo convencionales (~150 kDa) respecto a su aplicación clínica.
Olivia Cabanillas Bernal
core  

Assays to obtain vNAR fragments for Coccidioides spp detection

open access: yes, 2018
La fiebre del Valle de San Joaquín o Coccidioidomicosis (CM) es una enfermedad pulmonar causada por el hongo Coccidioides spp. La perturbación del suelo por humanos, animales o condiciones climáticas ocasiona la dispersión de esporas de Coccidioides en ...
JAMVIER BARUC LOPEZ TELLO
core  

Expresión recombinante de un dominio vNAR anti-EGFRvIII Epidermal Growth Factor Receptor presente en células tumorales, PAP realizado en el CIATEJ [PDF]

open access: yes, 2023
Este proyecto, denominado "Expresión recombinante de un dominio vNAR anti-EGFRvIII (Epidermal Growth Factor Receptor) presente en células tumorales", tiene como propósito general extraer y aislar una proteína específica (vNAR R426) con el fin de ...
Urzúa-TorresSeptién, Andrés
core  

Effect of a VNAR anti-VEGF165 in the treatment of cancer

open access: yes, 2018
Los VNARs se han probado como nuevos entes terapéuticos, basados en su estabilidad, capacidad de unión y penetración en los tejidos. El V13, un VNAR que reconoce al VEGF, se utilizó como molécula parental en la cual se insertaron cambios de aminoácidos ...
DALIA VANESSA MILLAN GOMEZ
core  

Home - About - Disclaimer - Privacy